Evidence map›Paper›PMID 38994970›Full record

ArticleCells2024

Exploring the Biosafety Potential of

Bela Vasileva, Natalia Krasteva, Kamelia Hristova-Panusheva, Penyo Ivanov, George Miloshev, Atanas Pavlov, Vasil Georgiev, Milena Georgieva

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Cells, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Bela VasilevaLaboratory of Molecular Genetics, Epigenetics and Longevity, Institute of Molecular Biology "Roumen Tsanev", Bulgarian Academy of Sciences, 1113 Sofia, Bulgaria.ORCID 0000-0002-8718-6412
Natalia KrastevaInstitute of Biophysics and Biomedical Engineering, Bulgarian Academy of Sciences, 1113 Sofia, Bulgaria.ORCID 0000-0001-7423-7412
Kamelia Hristova-PanushevaInstitute of Biophysics and Biomedical Engineering, Bulgarian Academy of Sciences, 1113 Sofia, Bulgaria.ORCID 0000-0001-8348-8336
Penyo IvanovLaboratory of Molecular Genetics, Epigenetics and Longevity, Institute of Molecular Biology "Roumen Tsanev", Bulgarian Academy of Sciences, 1113 Sofia, Bulgaria.
George MiloshevLaboratory of Molecular Genetics, Epigenetics and Longevity, Institute of Molecular Biology "Roumen Tsanev", Bulgarian Academy of Sciences, 1113 Sofia, Bulgaria.ORCID 0000-0003-2979-8899
Atanas PavlovLaboratory of Cell Biosystems, Institute of Microbiology, Bulgarian Academy of Sciences, 4000 Plovdiv, Bulgaria.
Vasil GeorgievLaboratory of Cell Biosystems, Institute of Microbiology, Bulgarian Academy of Sciences, 4000 Plovdiv, Bulgaria.ORCID 0000-0002-9234-0779
Milena GeorgievaLaboratory of Molecular Genetics, Epigenetics and Longevity, Institute of Molecular Biology "Roumen Tsanev", Bulgarian Academy of Sciences, 1113 Sofia, Bulgaria.ORCID 0000-0002-2371-7544

Funding

Bulgarian Science Fund DN11/15
6 · The paper itself

Abstract

The escalating elderly population worldwide has prompted a surge of interest in longevity medicine. Its goal is to interfere with the speed of ageing by slowing it down or even reversing its accompanying effects. As a field, it is rapidly growing and spreading into different branches. One of these is the use of nutraceuticals as anti-ageing drugs. This field is gaining massive popularity nowadays, as people are shifting towards a more natural approach to life and seeking to use natural products as a source of medicine. The present article focuses on the cellular effect of

Indexed as

EthanolMitochondriaPlant ExtractsAnimalsCell LineCell SurvivalDNA DamageHumansMiceReactive Oxygen SpeciesEthanolPlant ExtractsReactive Oxygen Speciesbiosafetycell cycle analysiscell viabilityHaberlea rhodopensisLep3 human embryonic fibroblast cellslongevity medicinemitochondrial structureneutral comet assaynutraceuticalsROS levels

Identifiers

PMID38994970
PMCPMC11240332

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.